A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.

J Immunother Cancer · 2019 · PMC6642527 · PMID 31324223

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

By stratifying tumor types, the negative clearance-response relationship was highly significant in NSCLC, and a non-significant trend was seen in RCC.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.